OLIF25™ /OLIF51™ Study
A Multi-Center, Prospective, Observational Study to Assess Outcomes for Patients Treated for Lumbar Spinal Conditions Using an OLIF25™ and/or OLIF51™Approach
Sponsor: Medtronic Spinal and Biologics
Terminated
Business Decision
Other terminated trials from Medtronic Spinal and Biologics
Other Degenerative Disc Disease trials with similar outcome
This observational or N/A phase trial investigates Degenerative Disc Disease and Scoliosis and is currently terminated or withdrawn. Medtronic Spinal and Biologics leads this study, which shows 12 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jul 2018 — Jan 2021 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2017 — Aug 2017 [monthly]
Recruiting NA
-
May 2017 — Jul 2017 [monthly]
Recruiting NA
-
Mar 2017 — May 2017 [monthly]
Recruiting NA
-
Feb 2017 — Mar 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Spinal and Biologics
For direct contact, visit the study record on ClinicalTrials.gov .